Physician profile
Mitchell Gauger
NPI 1235791005
$1,625.45
in general payments reported to CMS, 2019-2025
13 companies · $461 in 2025
The $461 reported for 2025 was more than what a typical Plastic Surgery provider received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $254 · 2022: $225 · 2023: $19.06 · 2024: $666 · 2025: $461.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,146.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,145.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Integra Lifesciences Corporation | $333.35 | 2021-2024 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Stryker Corporation | $277.70 | 2024-2025 | Smartlock, Na, Vsp System, Vsp Cranial |
| Depuy Synthes Sales INC. | $230.70 | 2021-2022 | |
| Tela Bio, INC. | $165.79 | 2024 | Ovitex 2s |
| Avita Medical Americas, LLC | $149.92 | 2025 | Recell |
| Polynovo North America LLC | $121.60 | 2024 | Novosorb Btm |
| Allergan, INC. | $105.27 | 2021 | |
| Musculoskeletal Transplant Foundation INC. | $85.71 | 2022 | |
| Mentor Worldwide LLC | $63.16 | 2025 | Mentor Memorygel Resterilizable Gel Sizer |
| Axogen | $34.85 | 2024 | Axoguard Nerve Connector, Avance Nerve Graft, Axoguard Nerve Cap |
| Microaire Surgical Instruments LLC | $24.64 | 2022 | |
| Medwest Associates | $19.06 | 2023 | |
| Helsinn Therapeutics (U.S.), INC. | $13.70 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mitchell Gauger listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.